Donor Government Funding for HIV in Low- and Middle-Income Countries in 2020
Donor government contributions to the Global Fund and UNITAID have been adjusted for an HIV-share to account for the fact that these multilateral organizations address other diseases and areas (see Methodology).
In 2021, the U.S. Congress appropriated an additional $3.5 billion in funding (beyond its regular contribution supporting HIV, TB, and malaria activities, which was flat in 2021 compared to the 2020 amount) to support the Global Fund’s efforts to address the COVID-19 pandemic. This funding is not included because it is for COVID-specific activities and cannot be attributed to HIV.
In 2020, some donor governments provided COVID-specific emergency contributions to the Global Fund and UNITAID in addition to their contributions for core activities. Specifically, France and Norway provided COVID-specific funding to UNITAID, while Canada, Denmark, Germany, Italy, Norway, and Sweden provided COVID-specific funding to the Global Fund. For the purposes of this report, these COVID-specific amounts have been excluded as they cannot be attributed to a specific area, such as HIV.
World Bank, Global Economic Prospects, June 2021.
Donor government disbursements are a subset of overall international assistance for HIV in low-and-middle-income countries, which also includes funding provided by other multilateral institutions, UN agencies, and foundations.
UNAIDS estimates that US$21.5 billion was available for HIV from all sources in 2020, expressed in 2019 USD. For purposes of this analysis, this estimate was converted to 2020 USD, or $21.7 billion. The UNAIDS estimate of total available resources for HIV includes disbursements from multilateral organizations in 2020 rather than the donor government contributions to these entities.